The ISCT Committee on the Ethics of Cell and Gene Therapy (ECGT) strives to:
Formerly known as the ISCT Presidential Task Force on the Use of Unproven and/or Unethical Cell and Gene Therapies (PTF).
Alexey BersenevMD, PhDYale UniversityUnited StatesHamid BidkhoriMD, PhDHudson Institute of Medical ResearchAustraliaWilson W. BryanMDIndependent Regulatory ConsultantUnited StatesMikey CreanePhDHAON Life ScienceIrelandMassimo DominiciMDFounding MemberUniversity Hospital of Modena, Reggio Emilia-Modena PoliclinicItalyMassimiliano GnecchiMD, PhD, FESCUniversity of PaviaItaly
Elena MaryamchikMDMemorial Sloan Kettering Cancer CenterUnited StatesJeanne LoringPhDScripps ResearchUnited StatesNicola RedfernN J Redfern Ltd.United KingdomBeth E. RoxlandJD, MBioethicsRoxland Consultants Ltd.United StatesSimona StankeviciuteMDParexel InternationalLithuaniaKunihiko SuzukiMBAMEDINET Co LTD.Japan
The ISCT ECGT Committee website contains numerous resources that strive to characterize unproven and unethical cell and gene interventions, and promote safe and effective practices worldwide.
View All Committees